AZN

AZD1222

COVID-19 Vaccine

Stage (next event)

Expected Date

Phase 3 (Data)

Q4 2020

Catalyst Info & Data Links

Mechanism of Action

MECHANISM OF ACTION / RATIONALE

  • AZD1222 (formerly ChAdOx1 nCoV-19), a recombinant adenovirus vaccine encoding the SARS-CoV-2 S protein

  • Description: Recombinant chimpanzee adenovirus vector expressing the SARS-CoV-2 S protein


  • source - Sheridan, C. (2020). Questions remain following first COVID-19 vaccine results. Nature Biotechnology.


Updated by HC

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See what the community is saying - click to see full post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon